Induction of tolerance by monoclonal antibody therapy
- PMID: 2938014
- DOI: 10.1038/320449a0
Induction of tolerance by monoclonal antibody therapy
Abstract
A major goal in immunology has been to find a means of selectively abolishing an individual's potential to mount an immune response to certain antigens, while preserving responsiveness to others. The facility to induce such specific immunological unresponsiveness in an adult would have major implications for tissue-grafting, the control of allergy and for treatment of autoimmune disease. Classical work has shown that immunosuppressive regimes, such as irradiation, anti-lymphocyte globulin or thoracic duct drainage, may facilitate tolerance induction. We describe here a technique by which the immune system of mice can be manipulated to be tolerant to certain protein antigens by administering these during a brief pulse of treatment with a monoclonal antibody directed to the L3T4 molecule on helper T lymphocytes. This technique has the potential to form the basis of a novel generalized means of tolerance induction.
Similar articles
-
Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.J Immunol. 1987 Sep 1;139(5):1426-31. J Immunol. 1987. PMID: 3114366
-
Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice.J Immunol. 1985 Sep;135(3):1698-701. J Immunol. 1985. PMID: 3160776
-
Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.J Immunol. 1984 Oct;133(4):2051-7. J Immunol. 1984. PMID: 6236262
-
Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.Transplant Proc. 1987 Apr;19(2 Suppl 1):1-6. Transplant Proc. 1987. PMID: 3105134 Review. No abstract available.
-
Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response.Transplant Proc. 1987 Apr;19(2 Suppl 1):17-20. Transplant Proc. 1987. PMID: 3105135 Review. No abstract available.
Cited by
-
Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.Immunol Res. 1988;7(2):113-35. doi: 10.1007/BF02918096. Immunol Res. 1988. PMID: 3134498 Review.
-
Boosting regulatory T cell function by CD4 stimulation enters the clinic.Front Immunol. 2012 Jun 18;3:164. doi: 10.3389/fimmu.2012.00164. eCollection 2012. Front Immunol. 2012. PMID: 22719741 Free PMC article.
-
Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?Springer Semin Immunopathol. 1998;20(1-2):165-80. doi: 10.1007/BF00832005. Springer Semin Immunopathol. 1998. PMID: 9836375 Review. No abstract available.
-
New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation.Ann Rheum Dis. 1997 Jan;56(1):5-11. doi: 10.1136/ard.56.1.5. Ann Rheum Dis. 1997. PMID: 9059133 Free PMC article. Review.
-
A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.Immunology. 1989 Aug;67(4):466-72. Immunology. 1989. PMID: 2570035 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources